Earnings Call · Q1 FY2026·2025-09-11

Q1 26EPS -24.44%·Rev n/aQ4 25EPS -22.22%·Rev n/aQ3 25EPS -5.75%·Rev n/aQ2 25EPS 0.00%·Rev n/a⚠ consensus missing

KalVista Pharmaceuticals, Inc. KALV

−3.8%1d on move date−4.6% vs SPY3d−11.5%5d−13.1%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more KALV calls or request research access.

More KALV calls Browse calls Request research access